Alterations of intestinal microbiota in liver cirrhosis with muscle wasting

Objectives: The intestinal microbiota plays an important role in the nutritional status and energy metabolism of the host. Liver cirrhosis is accompanied by muscle wasting or sarcopenia. The aim of this study was to to explore the changes in intestinal microbiota in patients with liver cirrhosis and muscle wasting by using metagenomics. Methods: This was a cross-sectional study of patients with (n = 30) and without (n = 30) muscle wasting and age and sex-matched healthy controls (n = 30) to evaluate changes in intestinal microbiota by metagenomic gene sequencing. Musclewasting was determined by the third lumbar vertebrae skeletal muscle index (L3 SMI). Results: The Shannon index, which represents species diversity, of patients in the muscle-wasting group (2.11 +/- 0.88) was lower than in the non-muscle-wasting group (2.64 +/- 0.68; P = 0.039), which was significantly lower than in the healthy control group (2.70 +/- 0.53; P = 0.023). There were 17 microbial species with significant differences in relative abundance between the two groups (linear discriminant analysis score >2; P < 0.05). The relative abundance of Escherichia coli, Peptostreptococcus stomatis, and Bacteroides uniformis showed the most significant association with L3 SMI. Conclusions: There were compositional alterations in intestinal microbiota in patients with liver cirrhosis and muscle wasting. L3 SMI is closely related to E. coli, P. stomatis, and B. uniformis in liver cirrhosis. Further interventional studies are needed to confirm whether improving intestinal microbiota can improve the nutritional status of patients with liver cirrhosis. (C) 2020 Elsevier Inc. All rights reserved.

Automated summary

The study identified compositional alterations in the intestinal microbiota of patients with liver cirrhosis and muscle wasting, with significant associations found between L3 SMI and Escherichia coli, Peptostreptococcus stomatis, and Bacteroides uniformis. Further interventional studies are needed to confirm the potential for improving nutritional status in liver cirrhosis patients by enhancing their intestinal microbiota.